New to Parola? Get 20% off on your first project

Synthetic Biology


parolanews infographic about synthetic biology

According to the Engineering Biology Research Consortium, Synthetic Biology (or SynBio) is the design and construction of new biological entities such as enzymes, genetic circuits and cells or the redesign of existing biological systems to meet specific performance criteria or solve specific problems. For example, SynBio can be harnessed to produce food with the same nutritional value as one produced using livestock, at a much lower environmental footprint.


According to Markets and Markets, the global synthetic biology market is expected to reach USD 8.84 billion by 2022, from an estimated 3.57 Billion in 2017, at a CAGR of 19.9%. The major factors propelling growth of this market include the growing range of applications of synthetic biology, rising R&D funding from government and private bodies, declining prices of DNA sequencing and synthesis, the increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. Recent advancements in CRISPR technology, which facilitates programmability and control of genetic material of almost any organism, may also be a potential driver of the industry. Between 2008 and 2014, the United States invested approximately US$820 million in synthetic biology research. The Defense Advanced Research Projects Agency (DARPA) funds much of the U.S. government’s research in the technology.


However, there also exists factors responsible for hampering growth of the market. These include biosecurity concerns, ethical issues and cuts in reimbursement leading to pricing pressure. Techniques like CRISPR gene editing and DNA synthesis could enable bioweapons development, according to a new National Academies report.
Synthetic biology also presents some patentability issues. Patenting in the field has revolved around four main components: parts, pathways, genomes and systems. Patentability typically revolves around novelty (35 USC 102) and non-obviousness (35 USC 103a) in view of the naturally occurring products on which the synthetic ones are based.

In this month’s issue of ParolNEWS, we look at the patenting trends in the field of Synthetic Biology.

Share This Newsletter

Share on facebook
Share on linkedin
Share on twitter
Share on email

Related ParolaNEWS

screenshot of page for digital twin

Digital Twin

The growth of Internet-of-Things (IoT), as well as other supporting technologies needed for Digital Twins are leading to a renewed interest in the concept of

parolanews newsletter screenshot for neural network hardware

Neural Network Hardware

The growing interest in artificial intelligence (AI) also stimulates the Artificial Neural Network market, now poised to reach a market size of $296 million by

graphic about artificial intelligence

Artificial Intelligence

We’re keeping a closer look at Artificial Intelligence for the past year, and our recent study still reveals that IBM is ahead of the pack

parolanews graphic about e-commerce


According WIPO, patents in E-commerce play an important role because of the amount of licensing, contracting out, outsourcing and strategic relations involved in this industry.

parolanews graphic about startups

Healthcare Informatics

As the medical community is continuously incorporating information technology, healthcare sciences, even cognitive science to better manage healthcare information, the global healthcare informatics market is

infographic for parolanews in 5G


5G (fifth generation) is a combination of communications technologies that can meet the increasing data demands of mobile users. These technologies include millimeter waves, small

Subscribe to our newsletter

  • Questions? Check our privacy policy.
  • This field is for validation purposes and should be left unchanged.
isometric illustration of girl writing on notebook

Join our list

  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.